| > Many of us are in a tough situation so we'll accept the crappy AZ The AZ is pretty much equal (at least) in effectiveness to the other vaccines. This is agreed by the UK regulators (and until Brexit the UK were considered expert enough to run the EU one), the EU regulators, the German regulators, etc, and now the US regulators (not yet approved, I know, but their opinion is now released). How many of these world-reknowned establishments need to say the same thing before you get it? By saying "crappy AZ" your choice of words is a major part of the problem. You are part of the problem. As for "competing with the likes of Pfizer", I have the greatest respect for the science behind Pfizer, Johnson & Johnson, and all the others - but with equal performance, at normal temperatures, at a fraction of the cost of the others, and with sub-licensed manufacturing around the world, the AZ vaccine is currently aiming to be the one that 90% of the global population will be relying on. The "crappy" Oxford/AstraZeneca vaccine is by a long way the world's best hope (in medical terms). It's very gracious of you to "accept the crappy AZ" (talk about ungrateful) - but if you're willing to take the benefit the least you could do is stop undermining it by posting rubbish on a thread discussing the very story that contradicts you. |
AZ's always been clouded in controversy from the botched trials, to the reduced effectiveness against variants up to the significant discomfort after vaccination in a non-negligible amount of people. And then there was the rare form of thrombosis, which is not 100% elucidated yet.
Why would anyone with a choice want AZ when there's Pfizer? And this is exactly what was happening all over Europe, but also in the US and Israel - people choose Pfizer in spite of the costs and complicated distribution.
It's particularly telling that the US prefers keeping tens of millions of doses of the super-awesome AZ on ice and continues with Pfizer.